Past Papers 3 Flashcards

1
Q

HAV vaccine

What type of vaccine is it?

A

Inactivated vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HAV outbreak

Who needs PEP?

<14 days since exposure

A

<14 days post exposure

  • liver disease/ immunosuppressed - Vaccine + HNIG*
  • <12 months old - Vaccine carers**
  • 12 months - 59 years - Vaccine
  • > 60 - Vaccine + HNIG

*ideally check HAV IgG before administering

** vaccine can be given >2 months of age, but is unlicensed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HAV outbreak

Who needs PEP?

> 14 days since exposure

A

> 14 days post exposure

  • liver disease/ immunosuppressed - Vaccine + HNIG if <28 days since exposure

1 household contact
- food handler - if high risk of acquiring infection, eg from small child at home with poor hygiene, and has direct contact with food items, then transfer to duties which do not involve food preparation until 30 days post exposure. If low risk of acquisition, just give hand hygiene advice only. Do not give vaccine if >14 days after exposure

  • non-food hander - hand hygiene advice only

> 1 household contact
- Vaccine everyone >12 months old. Only give to try and reduce further outbreak

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Baltimore classification of viruses

What is in each class?

A

I - dsDNA

II - ssDNA

III - dsRNA

IV - ssRNA +

V - ssRNA -

VI - ssRNA-RT

VII - dsDNA - RT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a plaque reduction neutralisation test? PRNT

A

The PRNT is a serological test which utilizes the ability of a specific antibody to neutralize a virus, in turn, preventing the virus from causing the formation of plaques in a cell monolayer.

Typically, the assay involves mixing a constant amount of virus with dilutions of the serum specimen being tested, followed by plating of the mixture onto a monolayer of host cells

The concentration of plaque forming units can be determined by the number of plaques formed after a few days.

A vital dye (eg, neutral red) is then added for visualization of the plaques and the number of plaques in an individual plate is divided by the original number of virions to calculate the percentage neutralization.

Depending on the virus, the plaque forming units are measured by microscopic observations, fluorescent antibodies, or specific dyes that react with the infected cell.

Interpretation is typically based on 50% neutralization, which is the last dilution of serum capable of inhibiting 50% of the total plaques (virions). Termed PRNT50 value

Currently, the PRNT test is considered the “gold standard” for detecting and measuring antibodies that can neutralize the viruses that cause many diseases. It has a higher sensitivity and is more specific than many other serological tests for the diagnosis of some viruses.

Very useful for vaccine studies, whereby you want to see what antibody titres are required to help prevent an infection/ reduce risk of severe disease

Time intensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are problems with a plaque reduction assay?

A

Time intensive - so not very helpful for diagnosing an acute infection. Better to do an EIA and measure antibody titres

if use incorrect cell line may not see virus infect cells correctly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are good uses for plaque reduction assays?

A

Very useful for vaccine studies, whereby you want to see what antibody titres are required to help prevent an infection/ reduce risk of severe disease

Very useful for diagnosing Flaviviruses such as Dengue. Flaviviruses have lots of cross-reactivity in EIA tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Solid organ transplant

What infections to screen for in donor?

A

HIV Ag/Ab

HBsAg/ Anti-HBc

Anti-HCV

HTLV 1/2

CMV IgG

EBV

Syphilis serology

Toxoplasma serology

If travel history -
West Nile Virus
Strongyloides
Coccidioides/ histoplasma
Trypanosomma Cruzi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is Sanger sequencing, and what is it used for?

A

determines sequence of nucleotides bases in a piece of DNA

99.99% accurate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Next Generation Sequencing?

What are benefits over Sanger method

A

NGS

  • higher throughput- massively parallel testing
  • higher depth reads - increased sensitivity
  • higher discovery power for mutants/ new viruses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the steps of Sanger sequencing?

A

The Sanger sequencing method consists of 6 steps:
(1) The double-stranded DNA (dsDNA) is denatured into two single-stranded DNA (ssDNA).

(2) A primer that corresponds to one end of the sequence is attached.

(3) Four polymerase solutions with four types of dNTPs (AGCT) but only one type of ddNTP (AGCT) are added. ddNTP are dideoxynucleotide triphsophates, which have oxygen atom removed from ribonucleotide, and cannot form a link to the next nucleotide thereby terminating chain elongation

(4) The DNA synthesis reaction initiates and the chain extends until a termination nucleotide is randomly incorporated.

(5) The resulting DNA fragments are denatured into ssDNA.

(6) The denatured fragments are separated by their size by gel electrophoresis and the sequence is determined.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are advantages of Sanger V NGS?

A

Sanger

Advantages
Fast and cost-effective for low target number
Established workflow
Simple data analysis
Longer reads (500-700 bps)

Disadvantages
Low sensitivity (~15–20% detection limit)
Low discovery power
Low scalability due to increasing sample input requirements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are advantages of NGS V Sanger?

A

NGS

Advantages
Higher sequencing depth for increased sensitivity (down to 1%)
Higher discovery power
Higher mutation resolution
More data generated with the same DNA quantity
Higher throughput

Disadvantages
Less cost-effective for low target number (1–20 targets)
Time-consuming for low target number (1–20 targets)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are available covid vaccines?

What is the target?

A

Spike protein target

mRNA vaccine
Pfizer-BioNTech
Moderna

Vector vaccine - adenovirus
AstraZeneca
Janssen Johnson/ Johnson

protein subunit - spike protein
Novavax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are reasons for vaccine hesitancy?

A

poor knowledge

religious beliefs

medical distrust

poor attitude of healthcare workers - e.g not offering or prompting

poor acces to services - e.g it is a big hassle to get the vaccine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can vaccine hesitancy be overcome?

A

Strategic campaigns - e.g schools and MMR, churches

information leaflets

multiple attempts - GP/ hospital/ antenatal/ school catch up

advertising/ social media engagement

celebrity endorsement

incentives - e.g money/ food

technology - email/ text to remind to book

education - allow information about vaccines to become available easily

17
Q

Business case for HCV antibody and RNA screening in national pregnancy program

What are pros for this?

A

identify an infectious disease earlier - can treat mother after delivery, and baby can be followed up. Also allows contact tracing

provides data about general population prevalence of HCV

provides opportunity to screen more people for BBV - proactive approach

18
Q

Business case for HCV antibody and RNA screening in national pregnancy program

What are cons for this?

A

Unnecessary anxiety - await RNA testing. 20% will clear spontaneously

No treatment available in pregnancy - so does not help baby

Low prevalence - high false pos rate

Increased cost of testing - lab equipment and staff. USA study has shown it to be cost-effective in specific sub-populations e.g opioid abuse areas

19
Q

Adenovirus infection in Hemopoietic stem cell transplant patient

What are possible clinical manifestations?

A

Pneumonia

Encephalitis

Hepatitis

Gastroenteritis

Haemorrhagic cystitis

Mortality in region 10-50%

20
Q

Adenovirus infection in Hemopoietic stem cell transplant patient

When should we treat?

A

Two positive results with level >10 000 copies/ml

However if patient severely unwell with high viral load, may initiate treatment early

In this patient group, cannot reduce immunosuppression

21
Q

Adenovirus infection in Hemopoietic stem cell transplant patient

Patient commenced on cidofovir

How long should this be continued for?

A

Continue unless nephrotoxicity develops

Continue until viral load undetectable on 2x occasions

22
Q

Cidofovir used for adenovirus disease in severely immunocompromised

What bloods should be taken prior to administration?

A

FBC
UE
Urine for proteinuria

If eGFR <55 or persistent proteinuria after hydration, then cidofovir should not be administered, unless benefits outweigh risks

23
Q

Cidofovir used for adenovirus disease in severely immunocompromised

What are dosing options?

A

1mg/kg 3 times a week dosing is preferred

5mg/kg once weekly, then every two weeks after the second dose.
i.e weeks 1,2,4,6,8

24
Q

Cidofovir used for adenovirus disease in severely immunocompromised

What else needs to be given with cidofovir?

A

Hydration - 1l fluids over 2 hours

Probencid - start 3 hours prior to cidofovir
it inhibits the reabsorption of urate at proximal convoluted tubule, increasing urinary excretion of uric acid, and decreasing urate levels. High urate associated with gout/ kidney stones and renal disease

25
Q

Cidofovir used for adenovirus disease in severely immunocompromised

Adenovirus isolated only in urine, and not the blood.

How would you treat?

A

If no systemic involvement, then intravesical cidofovir may be considered